25810
The front - runner 2nd generation rationally - designed therapeutics targeting the AR , abiraterone and enzalutamide have been shown to improve survival and clinical outcome for CRPC patients .
 None
Please list all entity words in the text that fit the category. Output format is "word1, word2". 
Option: Chemical 
Text: {0} 
Answer:
 None